Rationale: Reactive hyperemia (RH) in the forearm circulation is an important marker of cardiovascular health, yet the underlying vasodilator signaling pathways are controversial and thus remain unclear.
A fter ischemia caused by temporary arterial occlusion, there is significant vasodilation and a rapid marked increase in blood flow in most tissues, including the human forearm. 1 This phenomenon of reactive hyperemia (RH) is thought to occur as a result of myogenic and local metabolic or endothelial factors within the resistance vasculature and, thus, can be used as a test of microvascular function. 3 Attenuated RH responses have been documented in populations demonstrating a variety of risk factors that increase cardiovascular morbidity and mortality, including hypertension, 4-7 atherosclerosis, 8 peripheral artery disease, 9 congestive heart failure, 10 and advanced age. 11 Recently, peak RH flow was determined to be predictive of future cardiovascular events in a healthy population 12 as well as in at-risk patient populations, 13 and this predictive value may be greater than that of commonly assessed macrovascular function via flowmediated brachial artery vasodilation. 12, 14 Despite the use of the RH test as a measure of vascular health, the underlying mechanisms of local vasodilation that contribute to this response in humans are largely unknown.
Given the strong associations between impaired RH, cardiovascular disease risk, and attenuated endothelial-dependent and metabolic vasodilation, 15, 16 a variety of previous investigations in humans have attempted to determine the role of numerous endothelial-derived and metabolically dependent substances or pathways involved in the response, including nitric oxide (NO), 8, [17] [18] [19] [20] prostaglandins (PGs), 18, [21] [22] [23] ATPdependent potassium (K ATP ) channels, 17, 24 and adenosine. 22, 25, 26 The results of these studies are largely equivocal and, to date, even when the production or action of these substances is inhibited in combination, 17, 18, 22 a significant portion of both the peak and total RH remains unexplained. There is growing interest in vasodilation that occurs via non-NO and non-PG mechanisms due to hyperpolarization of endothelial and vascular smooth muscle cells. 27, 28 Endothelial-derived hyperpolarization (EDH) can be broadly categorized into 2 groups: classical EDH associated with activation of calcium-activated potassium channels (K Ca ) and subsequent direct electric communication or activation of inwardly rectifying potassium (K IR ) channels and Na + /K + -ATPase, resulting in hyperpolarization of vascular smooth muscle cells; and the second category of EDH involving diffusible factors such as H 2 O 2 and the cytochrome p450 metabolites (eg, epoxyeicosatrienoic acid). 29 In this context, we recently demonstrated the ability to block the local vasodilation to intra-arterial infusions of KCl via inhibition of K IR channels and Na + /K + -ATPase in the human forearm and further showed that these pathways can contribute to vasodilator responses to pharmacological stimulation of the endothelium 30 as well as increased metabolic demand. 31 Whether vascular hyperpolarization via K IR channel and Na + /K + -ATPase activation contributes to RH in humans has never been tested.
With this information as background, we directly tested the hypothesis that vascular hyperpolarization via K IR channels and Na + /K + -ATPase contributes to forearm RH after temporary arterial occlusion in healthy humans. Further, we sought to determine whether combined inhibition of NO and PGs attenuates RH, because several studies have demonstrated that individual inhibition of these endothelial pathways may not impact hyperemic responses to a variety of physiological stimuli, whereas combined inhibition can reveal a significant role in vascular control. 32, 33 Methods A detailed and expanded Methods section is available in the Online Data Supplement.
Subjects
With Colorado State University Institutional Review Board approval and after written informed consent, a total of 24 young healthy adults (18 men, 6 women; age, 23±1 years [range, 18-34 years]; weight, 73.1±1.5 kg; height, 175±1 cm; body mass index, 23.9±0.5 kg/m 2 ; forearm volume (FAV), 945±39 mL; means±SEM) participated in the present study. All studies were performed according to the Declaration of Helsinki.
Arterial Catheterization, Arterial Blood Pressure, and Heart Rate
A 20-gauge, 7.6-cm catheter was placed in the brachial artery of the nondominant arm under aseptic conditions after local anesthesia (2% lidocaine) for local administration of study drugs, blood sampling, and mean arterial pressure (MAP) measurement. Heart rate (HR) was determined using a 3-lead ECG (Cardiocap/5; Datex-Ohmeda, Louisville, CO).
Forearm Blood Flow and Vascular Conductance
Forearm blood flow (FBF) was measured via venous occlusion plethysmography using mercury-in-silastic strain gauges and techniques as previously described. 30 FBF was expressed as milliliters per deciliter of tissue per minute (mL/dL FAV per minute). As an index of forearm vasodilation and to account for individual differences in baseline vascular tone, forearm vascular conductance (FVC) was calculated as (FBF/MAP)×100, expressed as mL/dL FAV per minute per 100 mm Hg. Immediately after the release of the occlusion cuff for the RH, the same cuff cycled between inflation at ≈50 mm Hg (4 seconds) and deflation (3 seconds) to cause venous occlusion, and this yielded 1 blood flow measurement every 7 seconds for the first 56 seconds (8 flow measures). After 8 flow measures, the inflationdeflation cycle was changed back to 7:8 seconds, as was used at rest.
RH Protocol
After measurement of baseline FBF, the cuff on the upper arm was rapidly inflated to 200 mm Hg for 5 minutes of ischemia. This location and duration of ischemia were chosen to mimic the RH protocol used in investigations of the contributions of various endothelialderived vasodilator pathways to the RH response 18, 19, 22, 23 and, importantly, peak RH flow has recently been demonstrated to be more strongly associated with cardiovascular disease risk than measures of flow-mediated vasodilation. 12 After 5 minutes, the cuff was rapidly deflated and flow measures commenced for 2.5 minutes (150 seconds). To determine the effect of repeated bouts of RH, 8 additional young subjects were instrumented noninvasively and underwent 4 successive bouts of RH separated by 20 minutes of rest (see onlineonly Data Supplement for details).
Vasoactive Drug Infusion
All drug infusions were through the brachial artery catheter to create a local effect in the forearm and were completed during baseline measures before the arterial occlusion, and saline was used as a control infusate. Specific timing and duration of infusions is provided in the Experimental Protocols section.
To inhibit K IR channels, BaCl 2 (K IR channel inhibitor; 10% wt/vol BDH3238; EMD Chemicals, Gibbstown, NJ) was infused at 0.9 μmol/dL FAV per minute within an absolute range of 8 to 10 μmol/min for 5 minutes before each arterial occlusion. To inhibit Na + /K + -ATPase, ouabain octahydrate (Na + /K + -ATPase inhibitor; Sigma, St Louis, MO) was infused at 2.7 nmol/min for 15 minutes before arterial occlusion. 30, 34 In subsequent RH trials, ouabain was reinfused for 5 minutes before arterial occlusion to provide continuous inhibition. This approach of using BaCl 2 and ouabain to inhibit K IR channels and Na + /K + -ATPase, respectively, has been used previously by our group 30, 35 and others. 36, 37 We administered N G -monomethyl-l-arginine (l-NMMA; NO synthase inhibitor; Clinalfa/Bachem, Weil am Rhein, Germany) to inhibit the production of NO in combination with ketorolac (nonselective cyclooxygenase inhibitor; Hospira, Lake Forest, IL) to inhibit the synthesis of PGs. The doses of l-NMMA and ketorolac were 5 mg/min and 1200 µg/min, respectively, and were administered for 5 minutes 30 before arterial occlusion. 
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Experimental Protocols
In all experimental protocols, subjects rested quietly for 30 minutes after insertion of the catheter before the first experimental trial and for 20 minutes between each RH trial.
Protocol 1: Independent and Combined Effects of K IR Channel and Na + /K + -ATPase Inhibition
This protocol was designed to primarily address the role of K IR channels and Na + /K + -ATPase in the RH response. In total, 16 subjects participated in this protocol. Eight of these subjects (group 1) underwent RH trials during the following conditions: control (saline); independent K IR channel inhibition (BaCl 2 ); combined K IR channel and Na + /K + -ATPase inhibition (BaCl 2 plus ouabain); and inhibition of K IR channels, Na + /K + -ATPase, as well as NO and PGs (BaCl 2 plus ouabain plus l-NMMA plus ketorolac). In the other 8 subjects (group 2), the protocol was the same except that the second trial consisted of independent inhibition of Na + /K + -ATPase via ouabain versus BaCl 2 infusion.
Protocol 2: Effects of Combined Inhibition of NO and PGs
To further address the combined role of NO and PGs in RH and to assess the role of K IR channel and Na + /K + -ATPase activation, we performed a second protocol (n=8) that consisted of RH trials during the following conditions: control (saline); combined NO and PG inhibition (l-NMMA plus ketorolac); and inhibition of the production of NO and PGs as well as K IR channels and Na + /K + -ATPase (l-NMMA plus ketorolac plus BaCl 2 plus ouabain).
Protocol 3: Control Vasodilator Stimulus
In a subset of subjects (n=6), sodium nitroprusside (SNP; Nitropress; Hospira, Lake Forest, IL) was infused at 2 µg/dL FAV per minute for 5 minutes 38 during control (saline) conditions and after previous administration of all 4 antagonists (BaCl 2 plus ouabain plus l-NMMA plus ketorolac) as a negative control to confirm intact capacity of the forearm resistance vasculature to vasodilate.
Data Acquisition and Analysis
Data were collected and stored on a computer at 250 Hz and were analyzed offline with signal-processing software (WinDaq; DATAQ Instruments, Akron, OH). MAP was determined from the arterial pressure waveform. FBF was determined from the derivative of the forearm plethysmography signal. For resting hemodynamic measures, the average of the last minute of baseline was used. To quantify the RH response, we averaged and plotted values from each subject at all FBF time points (7, 14, 21, 28, 35, 42, 49, 56 , 60, 75, 90, 105, 120, 135, and 150 seconds postcessation of arterial occlusion) and the total reactive hyperemic FBF (area under the curve [AUC]) was determined as the sum of FBF above baseline at each time point. The peak RH FBF and vasodilation (FVC) was determined for each subject individually and these values were also averaged. In all subjects, these individual peaks occurred at the first, second, or third flow measurement. When FBF/FVC measurements for all subjects were averaged at each time point, the peak nearly always occurred at the first flow measurement (see Results). To quantify the impact of the vasoactive inhibitors, the magnitude of inhibition (%Δ) was calculated as (FBF peak/total inhibition-FBF peak/total control)/(FBF peak/total control)×100 and was always quantified from the control condition. For the SNP control trials, FBF was averaged across the last minute of baseline and SNP infusion.
Statistics
Data are presented as mean±SEM. Dynamic postocclusion FBF values were analyzed via 2-way repeated measures ANOVA (time×condition).
To make comparisons of peak and total RH FBF and baseline hemodynamics between each of the experimental conditions within a given protocol, we used 1-way repeated measures ANOVA. For comparisons between protocols, a 1-way ANOVA was used. In all cases, Student-Newman-Keuls post hoc pairwise comparisons were made when a significant F was observed. Significance was set a priori at P<0.05.
Results
No significant differences in subject characteristics were detected between the 3 experimental groups. Baseline systemic hemodynamics (HR, MAP) and FBF for all experimental protocols are presented in Table 1 , and baseline FVC values are presented in Table 2 . For all protocols, there were no significant changes in HR or MAP during or after the 5 minutes of arterial occlusion (data not shown).
Protocol 1: Independent and Combined Effects of K IR Channel and Na + /K + -ATPase Inhibition
In group 1 of protocol 1, subjects received BaCl 2 alone after the control trial to assess the independent role of K IR channels in RH. A representative tracing of 1 subject who participated in this protocol is provided in control conditions ( Figure 1A ) and after BaCl 2 infusion ( Figure 1B) . Baseline FBF and FVC are presented in Tables 1 and 2 . During RH, BaCl 2 significantly reduced the peak response (−50±6%; Figure 2A and 2B) and impaired FBF for the first 75 seconds (Figure 2A ). Taken together, the total RH FBF was also significantly reduced from control levels (−62±3%; Figure 2C ). The addition of ouabain did not further impact peak RH FBF (−60±7%; BaCl 2 versus BaCl 2 plus ouabain; P=0. 25) , but there was a strong trend toward an additional effect on total RH FBF (−82±4%; P=0.07).
The addition of l-NMMA plus ketorolac did not have a further impact (peak: −68±7%; total: −88±3%). Changes in peak vasodilation (FVC) paralleled those of FBF (Table 2 ). In group 2 of protocol 1, subjects received ouabain alone after the control trial to assess the independent role of Na + /K + -ATPase in RH ( Figure 3 ). Ouabain had no effect on peak RH FBF (2±6%; Figure 3A and 3B) but did significantly reduce FBF during 14 to 90 seconds of hyperemia, resulting in a significant attenuation of the total RH FBF (−44±12%; Figure 3C ). The addition of BaCl 2 significantly reduced peak RH FBF (−62±8%) as well as further reduced total RH FBF (−92±8%), whereas there was no additional effect of l-NMMA plus ketorolac on either peak (−63±7%) or total RH FBF (−94±8%). Changes in peak vasodilation (FVC) paralleled those for FBF ( Table 2 ).
Protocol 2: Effects of Combined Inhibition of NO and PGs
In protocol 2, we assessed the combined contribution of NO and PGs to RH and subsequent inhibition of K IR channels and Na + /K + -ATPase ( Figure 4 ). As would be expected with effective inhibition, l-NMMA plus ketorolac significantly reduced baseline FBF and FVC (Tables 1-3 ). The mean of the first FBF measures was augmented with l-NMMA plus ketorolac ( Figure 4A ); however, when each individual subject's peak response was averaged, this comparison only approached being significant (+18±8%; P=0.07; Figure 4B ). FBF was attenuated with l-NMMA plus ketorolac 30 to 60 seconds after the end of arterial occlusion ( Figure 4A ), yet the total RH FBF remained similar to control (−10±12%; P=0.24; Figure 4C ). The additional inhibition of K IR channels and Na + / K + -ATPase via BaCl 2 and ouabain, respectively, significantly attenuated both peak (−61±8%; Figure 4A and 4B) and total (−69±6%; Figure 4C ) RH FBF.
Comparison of RH Protocols
A summary of the relative (%Δ) effects of independent and combined roles of K IR channels and Na + /K + -ATPase and combined NO and PGs as compared with control conditions are presented in Figure 5 . In these pooled comparisons (BaCl 2 , n=8; ouabain, n=8; BaCl 2 plus ouabain, n=16; l-NM-MA plus ketorolac, n=8; BaCl 2 plus ouabain plus l-NMMA plus ketorolac, n=24), the reduction of peak FBF from BaCl 2 alone (−50±6%) to combined BaCl 2 plus ouabain (−61±6%) was similar (P=0.15). Total RH FBF was attenuated by BaCl 2 Figure 2 . Protocol 1: Independent effects of inwardly rectifying potassium (K IR ) channel inhibition (group 1). A, Forearm blood flow (FBF) response after 5 minutes of arterial occlusion during the following conditions: control (black circles); independent K IR channel inhibition (BaCl 2 ; dark grey triangles); combined K IR channel and Na + /K + -ATPase inhibition (BaCl 2 +ouabain; light grey squares); and combined inhibition of K IR channels, Na + /K + -ATPase, NO, and prostaglandins (BaCl 2 +ouabain+l-NMMA [N G -monomethyl-larginine]+ketorolac; white diamonds alone (−62±3%) and ouabain alone (−44±12%), and this effect was enhanced when these inhibitors were combined (−87±4%), nearly eliminating the hyperemic response to ischemia. l-NMMA plus ketorolac had no independent effects on peak (P=0.68) or total RH FBF (P=0.69), nor did they enhance any inhibition beyond that which occurred with BaCl 2 plus ouabain infusion (peak: −64±4%; P=0.60; AUC: −84±4%; P=0.62).
Protocol 3: Control Vasodilator Stimulus
Given the profound effects of our inhibitors on total RH, we wanted to confirm preserved vasodilator capacity after administration of BaCl 2 plus ouabain plus l-NMMA plus ketorolac.
To do so, SNP was administered in control (saline) conditions and at the end of the experimental protocol in a subgroup of 6 subjects. Baseline FBF and FVC were reduced after infusion of BaCl 2 plus ouabain plus l-NMMA plus ketorolac; however, there was no significant reduction in the absolute level, absolute change, or relative change in FBF and FVC during SNP infusion (Table 3 ).
Discussion
The primary novel finding from the current study is that activation of K IR channels and Na + /K + -ATPase and presumed subsequent vascular hyperpolarization explains nearly 90% of the total RH response to temporary ischemia, whereas NO and PGs have no significant combined role in this response ( Figure 5 ). K IR channels appear to be involved in both the peak and total FBF response; however, Na + /K + -ATPase only contributes to the total RH FBF and not the peak FBF. The present findings lend novel and significant mechanistic insight into this basic microvascular response that has been shown to have clinical relevance in a variety of conditions that increase cardiovascular disease morbidity and mortality.
Historical Overview of RH in Humans
Beginning with the initial observation ≈70 years ago of a rapid and profound hyperemia in response to a period of ischemia, there was interest in determining the underlying signals for this response. 1, 2, 7, 20, 23 Early experiments determined that an intact nervous system was not a requisite to observe this response, 2,10 and subsequent studies pursued investigating local mechanisms of vascular control that might be involved. 8, [17] [18] [19] [20] 22, 24 Alongside these studies aimed to determine the physiological basis of RH, the test itself began to be used as a measure of vascular health in a variety of at-risk populations. [4] [5] [6] [7] 9, 10 Different groups of subjects that demonstrated endothelial dysfunction as commonly assessed by intra-arterial infusion of endothelium-dependent vasodilators (eg, acetylcholine) or flow-mediated vasodilation of the brachial artery were shown to have attenuated RH responses. [4] [5] [6] [7] 9, 10 These associations among cardiovascular disease, endothelial health, and impaired RH have further stimulated an interest in the potential underlying mechanisms of this response. Importantly, recent evidence indicates that peak RH flow in response to 5 minutes of ischemia (via upper arm cuff inflation) may in fact be a better predictor of cardiovascular events than the more commonly assessed brachial flow-mediated vasodilation. 12 Thus, elucidating the mechanisms underlying this physiological response has clear significant clinical implications. Several potential mediators and downstream targets underlying RH have been postulated and experimentally tested in humans and in experimental animals. Because of the ischemic nature of the stimulus, classic metabolic candidates for regulating RH include adenosine or K ATP channel activation. Augmenting adenosine signaling through caffeine (adenosine receptor antagonist) withdrawal or dipyridamole (inhibitor of cellular uptake of adenosine) does improve RH; however, direct inhibition of adenosine receptors (via theophylline or caffeine) does not impair peak RH FBF 22, 26 and has a minimal effect on total FBF. 22 Similarly, results from inhibition of K ATP channels have been equally as unsuccessful in explaining RH. Inhibition of K ATP channels via sulfonylureas, such as tolbutamide or glibenclamide, modestly reduces total RH FBF but has no impact on the peak response in some studies, 17, 24 whereas other investigators have demonstrated no effect of K ATP channel inhibition on either peak or total RH. 39
Endothelium-Derived NO and PGs Contribute Little to RH in Humans
It is well-known that endothelial-derived NO contributes to cardiovascular health in humans because of its multifaceted cardioprotective properties. 27 Whether NO mediates RH was a logical proposition and has been investigated in a variety of existing studies. 8, [17] [18] [19] [20] There is discrepancy within the literature, and our present finding that NO (in combination with PGs) does not contribute to peak RH FBF fits with the results of most, 5, 20, 36, 40 but not all, 8, 41 of these studies. Some of the previous work has shown a modest role for NO in the total hyperemic response. 17, 18, 20 Additionally, previous studies demonstrated only a minimal contribution of endothelial-derived PGs to peak or total RH. 18, 21, 22 However, it is important to note that significant cross-talk occurs between these 2 endothelial pathways, such that inhibition of 1 pathway often does not impact vascular responses to a variety of stimuli, whereas combined inhibition reveals a significant role. 32, 33 Only 1 study to date showed inhibition of NO and PGs in combination, and this was performed with intra-arterial l-NMMA and oral ibuprofen. 18 In this previous study, there was no impact on the peak change in FBF in response to ischemia, whereas there was some reduction (≈35%) in the prolonged hyperemic response. 18 Our current findings agree with these observations that even in combination NO and PGs do not contribute to peak RH FBF, and although we observed a reduction in absolute FBF in the latter portion of RH, this was not of sufficient magnitude to impair the total RH FBF (Figure 4 ). An interesting observation in the present study was that peak RH was somewhat augmented after combined NO and PG inhibition, and this could also reflect a critical role for vascular hyperpolarization in the response because NO is capable of suppressing EDH-mediated vasodilation. 42 Although presently unclear, another explanation for this augmented response is our inhibition of cyclooxygenase may have shifted arachadonic acid to the cytochrome p450 pathway, thus increasing the production of epoxyeicosatrienoic acids to cause additional vasodilation. 27
Critical Role for K IR Channel and Na + /K + -ATPase Activation in RH in Humans
Based on our assessment in the present study, there is a prominent role for K IR channels and Na + /K + -ATPase in RH in humans ( Figure 5 ). Interestingly, only K IR channel activation, but not Na + /K + -ATPase, contributed to the peak RH FBF. Selective inhibition of K IR channels reduced the peak hyperemic response ≈50%, and a total of ≈60% was observed when inhibition of Na + /K + -ATPase was performed simultaneously. Inhibition of K IR channels and Na + /K + -ATPase independently reduced the total RH FBF by ≈60% and ≈40%, respectively, and this effect was enhanced when these were inhibited in combination. In this context, there was a remarkable reduction in the total response (−87±4%) from control, nearly abolishing RH. Collectively, the magnitude of the observed attenuation attributable to K IR channel inhibition on peak hyperemia Figure 5 . Summary: Effects of inhibition of inwardly rectifying potassium channels, Na + /K + -ATPase, nitric oxide (NO) and prostaglandins on peak and total reactive hyperemia. Combined results from the 3 experimental protocols are presented for relative impact (%Δ) on both peak (A) and total (B) reactive hyperemic forearm blood flow (FBF) in each experimental condition (BaCl 2 , n=8; ouabain, n=8; BaCl 2 +ouabain, n=16; l-NMMA [N G -monomethyl-l-arginine]+ketorolac, n=8; BaCl 2 +ouabain+l-NMMA+ketorolac, n=24). BaCl 2 reduced peak FBF and this attenuation was unchanged with the addition of ouabain or l-NMMA+ketorolac. Neither ouabain alone nor l-NMMA+ketorolac attenuated peak FBF. BaCl 2 and ouabain both independently reduced total FBF and, in combination (BaCl 2 +ouabain), the reduction was enhanced. There was no additional reduction by l-NMMA+ketorolac, nor did l-NMMA+ketorolac independently reduce total FBF. *P<0.05 vs zero; †P<0.05 vs BaCl 2 ; ‡P<0.05 vs ouabain. September 27, 2013 and combined K IR and Na + /K + -ATPase inhibition on the total hyperemic response are by far the greatest in the known studies to date on this topic.
Endothelium-dependent vasodilation that occurs beyond NO and PGs causes hyperpolarization of endothelial cells and vascular smooth muscle cells. 27 Classic EDH is sensitive to inhibition of K Ca channels which when activated, cause hyperpolarization of endothelial and smooth muscle cells through direct electric communication or stimulation of K IR channels and Na + /K + -ATPase. 29 Our finding of a significant role for K IR channel and Na + /K + -ATPase activation in RH in humans is consistent with the classic proposed mechanism of EDH. However, we must also recognize that the RH response may be endothelium-independent but still occurs through vascular smooth muscle cell hyperpolarization. 28 Recently, K IR channels have been shown to be particularly important for the amplification of hyperpolarizing stimuli because they are directly responsive to changes in membrane potential 43 and, thus, this unique property may explain the profound impact of BaCl 2 administration we observed on both peak and total RH. We are not able to address cell-specific issues related to K IR and Na + /K + -ATPase activation that we observed in the present study because of the limitations of our human in vivo model.
Experimental Considerations
All of the inhibitors used were administered before arterial occlusion and RH. This may lead one to question the efficacy of our inhibitors after 5 minutes of occlusion and subsequent large increases in blood flow. Although not directly assessed, we used doses previously established in our laboratory 30 and, given the large magnitude of the effects on peak and total RH FBF we observed, we do not think this consideration affects our primary conclusions. If anything, we may be potentially underestimating a role for K IR channels and Na + /K + -ATPase in RH. Further, we show that RH responses are largely repeatable over time, with only a slight decline (−9±5%) in peak RH in the fourth trial as compared with the first trial (Online Figure I in the online-only Data Supplement) and no change in AUC. Thus, the marked impact of BaCl 2 and ouabain we observed cannot be attributed to reduced responses with repeated trials. BaCl 2 has been demonstrated to be primarily selective for K IR channels up to a concentration of 100 µmol/L. 44 Dawes et al 36 demonstrated that a dose at half of what we used increased antecubital venous plasma concentrations in the infused forearm to 50 µmol/L and, thus, it can be assumed that our dose would result in concentrations within the selective range for K IR channels. A direct assessment of the selectivity of BaCl 2 for K IR channels is difficult in humans because it is not possible to make membrane potential measurements or isolate selective stimulation of this channel. Along these lines, at greater concentrations, BaCl 2 has been shown to inhibit other potassium channels, most prominently K ATP channels. Although we believe that BaCl 2 in the dose we administered is selective for K IR channels, if we are in fact inhibiting K ATP channels, this likely does not provide an alternative explanation for our findings because the majority of existing data show little to no impact of inhibiting K ATP channels on peak or total RH. 17, 24, 39 Further, our group 30, 31, 35 and others 36, 37 have demonstrated that each of the pharmacological inhibitors we used in this investigation does not impact overall vascular responsiveness and does not have systemic effects in the doses used.
Presently, the exact stimulus for vascular hyperpolarization in response to local ischemia is unknown. Potential candidates include substances that have been shown to cause vasodilation through K IR channels or Na + /K + -ATPase, such as K +30 , 45 ATP, 30 bradykinin, 37 H 2 O 2 , 46 and epoxyeicosatrienoic acids, 47 and it is possible that concentrations of these substances may increase during ischemia, as has been observed in animal models, particularly in the coronary circulation. 48 However, to the best of our knowledge, limited studies in humans have made interstitial measures of the candidate substances during ischemia in skeletal muscle and, to date, no significant increases have been observed. 49 Alternatively, evidence suggests that mechanosensitive mechanisms such as the myogenic response and stretch of endothelial cells contribute to the earliest portion of RH. 40 In this context, recent data indicate that low intravascular pressure can stimulate transient receptor potential channels that elicit changes in endothelial cell calcium, which can stimulate vasodilation via hyperpolarization, 50 and this might also serve as a stimulus for K IR channel or Na + /K + -ATPase activation. Identifying the stimulus for K IR channel and Na + /K + -ATPase activation that occurs during RH represents an intriguing future area of research and potentially would provide valuable insight into explaining impaired RH responses in clinical populations.
Conclusions
After temporary arterial occlusion, there is a significant increase in blood flow in the forearm vasculature of humans, the magnitude of which reflects microvascular function and is an important marker of overall vascular health and future cardiovascular disease risk. Here, we show that the majority of this response, in terms of both the initial peak hyperemia as well as the total hyperemia above baseline that occurs throughout the duration of the response, depends on activation of K IR channels and Na + /K + -ATPase. Additionally, our findings support the previous investigations that showed little to no role for NO and PGs in RH in humans, despite associations between RH and endothelial function. [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] Given the strong relation between attenuated RH responses and cardiovascular disease morbidity and mortality, 12 and as a result of this study on RH and vascular hyperpolarization via K IR channels and Na + /K + -ATPase, these vasodilator pathways present an exciting future direction for studies in patient populations and suggest that vascular health may extend beyond the commonly assessed NO bioavailability. Moreover, these findings could be particularly important for populations that exhibit microvascular dysfunction and may serve as a target for specific therapies to improve microvascular blood flow control in humans.
